4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
10.70
-0.49 (-4.38%)
At close: Dec 5, 2025, 4:00 PM EST
10.70
0.00 (0.00%)
After-hours: Dec 5, 2025, 5:01 PM EST
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $611.35 million as of December 5, 2025. Its market cap has increased by 58.95% in one year.
Market Cap
611.35M
Enterprise Value
268.81M
1-Year Change
58.95%
Ranking
Category
Stock Price
$10.70
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has increased from $580.38M to $611.35M, an increase of 5.34%. That is a compound annual growth rate of 1.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 639.34M | 148.30% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | 1.10B | 89.22% |
| Dec 11, 2020 | 580.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |